BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6777866)

  • 1. Degradation of amyloid-related serum protein SAA by a component present in rabbit and human serum.
    Skogen B; Natvig JB; Bøorresen AL; Berg K
    Scand J Immunol; 1980; 11(6):643-8. PubMed ID: 6777866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum.
    Skogen B; Børresen AL; Natvig JB; Berg K; Michaelsen TE
    Scand J Immunol; 1979; 10(1):39-45. PubMed ID: 224449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of anti-canine serum amyloid A (SAA) serum and purification of SAA from canine high-density lipoprotein.
    Yamamoto S; Miyaji S; Ashida Y; Otabe K; Momotani E; Rikihisa Y
    Vet Immunol Immunopathol; 1994 May; 41(1-2):41-53. PubMed ID: 8066995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid A protein generates pre beta 1 high-density lipoprotein from alpha-migrating high-density lipoprotein.
    Miida T; Yamada T; Yamadera T; Ozaki K; Inano K; Okada M
    Biochemistry; 1999 Dec; 38(51):16958-62. PubMed ID: 10606531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA).
    Marhaug G; Sletten K; Husby G
    Clin Exp Immunol; 1982 Nov; 50(2):382-9. PubMed ID: 7151331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein.
    Benditt EP; Eriksen N; Hanson RH
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4092-6. PubMed ID: 226994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid protein SAA is associated with high density lipoprotein from human serum.
    Benditt EP; Eriksen N
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4025-8. PubMed ID: 198813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A simple separative method for measuring serum amyloid A in high-density-lipoprotein and low-density-lipoprotein fractions using the phosphotungstic acid-Mg2+ precipitation procedure].
    Shishino K; Ochi M; Murase M; Osawa H; Makino H
    Rinsho Byori; 2007 Apr; 55(4):319-24. PubMed ID: 17511261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response.
    Frame NM; Jayaraman S; Gantz DL; Gursky O
    J Struct Biol; 2017 Dec; 200(3):293-302. PubMed ID: 28645735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of protein SAA to an AA-like fragment by enzymes of monocytic origin.
    Skogen B; Thorsteinsson L; Natvig JB
    Scand J Immunol; 1980; 11(5):533-40. PubMed ID: 6155692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of amyloid proteins by different serine proteases.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Oct; 14(4):389-96. PubMed ID: 6461061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein.
    Sato M; Ohkawa R; Yoshimoto A; Yano K; Ichimura N; Nishimori M; Okubo S; Yatomi Y; Tozuka M
    Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27422844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin interactions with apoA1 and SAA in inflammation-associated HDL.
    Digre A; Nan J; Frank M; Li JP
    Biochem Biophys Res Commun; 2016 May; 474(2):309-314. PubMed ID: 27105909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of senile amyloid--related antigenic substance (SASSAM) from mouse serum. Apo SASSAM is a low molecular weight apoprotein of high density lipoprotein.
    Higuchi K; Matsumura A; Hashimoto K; Honma A; Takeshita S; Hosokawa M; Yasuhira K; Takeda T
    J Exp Med; 1983 Nov; 158(5):1600-14. PubMed ID: 6415208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A protein in very low density--and high density lipoproteins during the course of acute myocardial infarction.
    Feussner G; Schuster M; Ziegler R
    Electrophoresis; 1991 Apr; 12(4):283-6. PubMed ID: 2070782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and mapping of antigenic determinants of serum amyloid A (SAA) protein utilizing sequence-specific immunoglobulins and Eu3+ as a specific probe for time-resolved fluorometric immunoassay.
    Malle E; Münscher G; Müller T; Vermeer H; Ibovnik A
    J Immunol Methods; 1995 May; 182(1):131-44. PubMed ID: 7769239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The primary structure of rabbit serum amyloid A protein isolated from acute phase serum.
    Syversen PV; Juul J; Rygg M; Sletten K; Husby G; Marhaug G
    Scand J Immunol; 1993 Apr; 37(4):447-51. PubMed ID: 8469927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of bacterial lipopolysaccharide with acute-phase rabbit serum and isolation of two forms of rabbit serum amyloid A.
    Tobias PS; McAdam KP; Ulevitch RJ
    J Immunol; 1982 Mar; 128(3):1420-7. PubMed ID: 7057038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII.
    Husebekk A; Skogen B; Husby G
    Scand J Immunol; 1987 Apr; 25(4):375-81. PubMed ID: 3107118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum amyloid A (SAA)-induced remodeling of CSF-HDL.
    Miida T; Yamada T; Seino U; Ito M; Fueki Y; Takahashi A; Kosuge K; Soda S; Hanyu O; Obayashi K; Miyazaki O; Okada M
    Biochim Biophys Acta; 2006 Apr; 1761(4):424-33. PubMed ID: 16651021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.